If it Ain’t Broke, Break it
Gene Editing Brings New Prostate Cancer Insights
By Anette Breindl
Friday, October 11, 2013
Most people tend to think of gene editing as a way to repair faulty genes. But a team from the University of Minnesota has gained new scientific insights into prostate cancer by taking the opposite tack. By using gene editing to introduce androgen receptor gene rearrangements that are seen in patients with castration-resistant prostate cancer into animals, they were able to show that such rearrangements drive resistance to current prostate cancer drugs because the rearranged version of the androgen receptor no longer needs to be activated by androgens.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.